Aggrecanase: The Family and Its Inhibitors

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Aggrecanase: The Family and Its Inhibitors

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 4(3): 251-264.

Author(s): R.- Q. Liu and J M Trzaskos.

Affiliation: Inflammation and Immunology Biology, Pharmaceutical Research Institute, Bristol Myers Squibb Co.,Princeton, NJ 08540, USA.


Osteoarthritic joint disease is characterized by the progressive loss of articular cartilage resulting in functional impairment, pain and discomfort. The major components in cartilage, collagen and aggrecan, are lost during disease through the action of degradative proteolytic enzymes. The proteases responsible for aggrecan degradation are termed aggrecanases. The aggrecanases represent a family of enzymes with great therapeutic potential as targets for the treatment of osteoarthritis. Here we review the family of aggrecanases and the progress made toward the identification of potent and selective enzyme inhibitors for use as therapeutic agents.


aggrecanase, adamts, cartilage, osteoarthritis, mmp, aggrecan, protease, adam.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 4
Issue Number: 3
First Page: 251
Last Page: 264
Page Count: 14
DOI: 10.2174/1568014054065186
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science